High-Risk Medications: $20M Jury Verdict Follows Opioid Administration in Presence of Known Allergy
May 24, 2017 | Strategic Insights for Health System
An Alabama jury awarded $20 million to the daughter of a patient who suffered irreversible damage when opioids were administered to her despite her documented allergy to the drug class.
The patient was admitted to the defendant subacute nursing facility for short-term rehabilitation with the goal of returning home to live with her daughter. One week after admission to the facility, the patient was transferred to the hospital for evaluation of mental status changes. A computed tomography scan indicated no acute process; the...